The Sensitivity to Cytosine Arabinoside of the Blast Progenitors of Acute Myeloblastic Leukemia

• Published in: Blood 1986-03, Vol.67 (3), p.762-769
• Main Authors: Nara, Nobuo, Curtis, J.E., Senn, J.S., Tritchler, D.L., McCulloch, E.A.
• Format: Article
• Language: English
• Subjects: Adult; Aged; Antineoplastic agents; Biological and medical sciences; Cell Survival - drug effects; Colony-Forming Units Assay; Cytarabine - pharmacology; Cytarabine - therapeutic use; Dose-Response Relationship, Drug; Doxorubicin - pharmacology; General aspects; Humans; Leukemia, Myeloid, Acute - drug therapy; Leukemia, Myeloid, Acute - pathology; Medical sciences; Methylcellulose; Middle Aged; Pharmacology. Drug treatments; Suspensions; Tumor Stem Cell Assay
• ISSN: 0006-4971; 1528-0020
• DOI: 10.1182/blood.V67.3.762.762

Two culture methods are available for the study of the blast cells of acute myeloblastic leukemia (AMD. One is an assay for clonogenic precursors; it depends on their ability to form blast colonies in culture in the presence of methyl-cellulose and suitable growth factors. The other assesses the growth of blast cells in suspension culture, where growth is measured by increasing numbers of clonogenic cells. We have compared the two methods as assays for the cytotoxic effects of the chemotherapeutic drug cytosine arabinoside (Ara-C). Marked patient-to-patient variation was found using either method; however, the slopes of the dose-response curves were usually greater when cells were exposed to drug in suspension rather than in methyl-cellulose. Control experiments showed that the difference could not be explained by drug carry-over from the suspension cultures to the methylcellulose plates when clonogenic cells in the suspensions were assessed. Further, the survival curves for Adriamycin were very similar, regardless of which assay was used. No correlation was found between D10 Ara-C values measured in suspension or in methylcellulose. However, a significant association with outcome was found between D10 Ara-C in suspension and response to treatment with a regimen in which Ara-C was the only chemotherapeutic agent used. No such association was detected when the D10 values obtained with the clonogenic assay were compared with outcome for the same group of 15 patients. Finally, a feasibility experiment was performed in which blast cells were exposed to Ara-C repeatedly during exponential growth over 238 days. A dose-related inhibition of growth was observed; no evidence was seen of emerging drug-resistant cells. Nor did the morphology of the cells change as a result of drug exposure. We conclude that drug sensitivities of AML blast cells in culture are dependent on measurement methods, even when techniques affecting cell proliferation are compared. Measurements of drug sensitivity in culture may best be interpreted when the bases of the assay systems are understood.